LyondellBasell Industries (NYSE:LYB) Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. lowered its stake in LyondellBasell Industries (NYSE:LYB) by 9.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 55,952 shares of the specialty chemicals company’s stock after selling 5,949 shares during the quarter. Pacer Advisors Inc.’s holdings in LyondellBasell Industries were worth $4,156,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in LYB. HighTower Advisors LLC boosted its holdings in LyondellBasell Industries by 18.2% during the third quarter. HighTower Advisors LLC now owns 1,038,687 shares of the specialty chemicals company’s stock worth $99,557,000 after buying an additional 159,803 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of LyondellBasell Industries by 3.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 5,229,416 shares of the specialty chemicals company’s stock valued at $501,501,000 after purchasing an additional 187,150 shares during the period. Quantinno Capital Management LP increased its stake in LyondellBasell Industries by 23.1% in the 3rd quarter. Quantinno Capital Management LP now owns 61,897 shares of the specialty chemicals company’s stock worth $5,936,000 after purchasing an additional 11,610 shares in the last quarter. Fifth Third Wealth Advisors LLC raised its holdings in LyondellBasell Industries by 202.4% during the 4th quarter. Fifth Third Wealth Advisors LLC now owns 12,986 shares of the specialty chemicals company’s stock worth $964,000 after buying an additional 8,691 shares during the period. Finally, Sound Income Strategies LLC lifted its stake in LyondellBasell Industries by 8.1% during the fourth quarter. Sound Income Strategies LLC now owns 271,626 shares of the specialty chemicals company’s stock valued at $20,174,000 after buying an additional 20,310 shares in the last quarter. 71.20% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

LYB has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft reduced their price target on shares of LyondellBasell Industries from $100.00 to $94.00 and set a “hold” rating for the company in a research report on Monday, November 4th. Mizuho decreased their target price on LyondellBasell Industries from $97.00 to $85.00 and set a “neutral” rating for the company in a research report on Monday, December 9th. Morgan Stanley reduced their price objective on LyondellBasell Industries from $110.00 to $90.00 and set an “overweight” rating for the company in a research note on Monday, January 13th. Piper Sandler restated a “neutral” rating and set a $95.00 price objective (down from $112.00) on shares of LyondellBasell Industries in a research report on Tuesday, January 7th. Finally, Wells Fargo & Company dropped their target price on LyondellBasell Industries from $105.00 to $95.00 and set an “overweight” rating on the stock in a report on Tuesday, December 10th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $94.33.

LyondellBasell Industries Trading Down 2.3 %

LyondellBasell Industries stock opened at $76.04 on Friday. LyondellBasell Industries has a one year low of $72.21 and a one year high of $107.02. The company’s fifty day moving average price is $76.76 and its two-hundred day moving average price is $87.49. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.13 and a quick ratio of 1.25. The company has a market capitalization of $24.69 billion, a price-to-earnings ratio of 11.57, a PEG ratio of 5.07 and a beta of 1.06.

LyondellBasell Industries (NYSE:LYB) last issued its quarterly earnings data on Friday, November 1st. The specialty chemicals company reported $1.88 earnings per share for the quarter, missing analysts’ consensus estimates of $1.98 by ($0.10). LyondellBasell Industries had a net margin of 5.29% and a return on equity of 17.05%. The company had revenue of $10.33 billion during the quarter, compared to the consensus estimate of $10.60 billion. During the same period in the previous year, the business posted $2.46 earnings per share. The firm’s revenue was down 2.8% on a year-over-year basis. On average, analysts forecast that LyondellBasell Industries will post 6.48 earnings per share for the current fiscal year.

LyondellBasell Industries Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, December 9th. Stockholders of record on Monday, December 2nd were given a $1.34 dividend. This represents a $5.36 dividend on an annualized basis and a dividend yield of 7.05%. The ex-dividend date was Monday, December 2nd. LyondellBasell Industries’s dividend payout ratio is 81.58%.

Insider Transactions at LyondellBasell Industries

In other LyondellBasell Industries news, Director Robin W.T. Buchanan purchased 5,000 shares of the stock in a transaction dated Friday, December 13th. The shares were bought at an average cost of $76.06 per share, with a total value of $380,300.00. Following the completion of the transaction, the director now owns 18,175 shares in the company, valued at $1,382,390.50. This trade represents a 37.95 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.11% of the stock is owned by corporate insiders.

LyondellBasell Industries Company Profile

LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally. The company operates in six segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology.